(Total Views: 208)
Posted On: 03/25/2019 6:40:46 AM
Post# of 157807
Yes, I forgot about IND for colon cancer ,
but as once Dr NP answered in e-mail my Q about that ( I posted his answer on IHUB at the time )
They want to have approval of IND for metastatic colon cancer , valuation of our company will improve , but they not sure if they will need to do actual clinical study since pre-clinical study are very , very good ,
and if positive study with TNBC they may just try for approval by mode of action , as it happened with Keytruda in the past.
Those things should be happening soon , I believe that lately they concentrate on BLA and TNBC , but other things like .
Mono,
IND for colon cancer,
GvHD,
MS.
news will be coming relatively soon..
but as once Dr NP answered in e-mail my Q about that ( I posted his answer on IHUB at the time )
They want to have approval of IND for metastatic colon cancer , valuation of our company will improve , but they not sure if they will need to do actual clinical study since pre-clinical study are very , very good ,
and if positive study with TNBC they may just try for approval by mode of action , as it happened with Keytruda in the past.
Those things should be happening soon , I believe that lately they concentrate on BLA and TNBC , but other things like .
Mono,
IND for colon cancer,
GvHD,
MS.
news will be coming relatively soon..
(0)
(0)
